In 2023, Howard Horn earned $184.81K in total compensation at Ultragenyx Pharmaceutical, including $124.81K salary and $60.00K bonus. Most recently sold 14,930 shares in Oct 2024. Currently holds stock worth $4.97M. 2+ years at the helm of Ultragenyx Pharmaceutical.
Compensation History
Annual executive compensation data for Howard Horn, including salary, bonuses, and stock awards.
Year
2023
Total Compensation
$184.81K
Salary
$124.81K
Bonus
$60.00K
Other
$0.00
Salary
$124.81KBoard Justification
The compensation philosophy aims to attract and retain skilled executives while aligning their interests with stockholders through performance-based incentives.
Bonus
$60.00KBoard Justification
Sign-on bonus under Mr. Horn’s offer letter, paid in 2023.
Other Compensation
$0.00Board Justification
No other compensation reported for Mr. Horn in 2023.
Restricted Stock
Board Justification
No stock was vested in 2023 as Mr. Horn joined the company in October 2023.
Performance Metrics
Mr. Horn was not eligible for annual bonuses or performance metrics in 2023 due to his start date after September 30, 2023.
Howard Horn
CEO of Ultragenyx Pharmaceutical
Education
B.A. in Economics from Princeton University, MBA from the Wharton School of the University of Pennsylvania
Field of Expertise
Finance & Banking - Finance
Sector of Economy
Healthcare
Born
January 1, 1977 - 48 years ago
CEO of Ultragenyx Pharmaceutical for
2 years 2 months (Oct 2023 - Present)
Previous Experience
Executive Vice President and Chief Financial Officer at Vir Biotechnology, Inc.
Other Ultragenyx Pharmaceutical CEOs
Holdings
Track Howard Horn's stock holdings and portfolio value over time.
Total Stock Sold
$804.28K
$804.28K
14,930 RARE shares
What if they kept their stock?
If Howard Horn didn't sell their stock, today they would have:
Extra RARE14,930 shares worth $540.47K.
This is -32.8% and $263.81K less than what they got when they sold the stock.
Insider Trading
Howard Horn's recent stock transactions, purchases, and sales filed with the SEC.
$787.71K
RARE at $52.76/share
Oct 10, 2024
Sale
19,400 shares
RARE
Mar 1, 2024
Received
80,366 shares
RARE
Oct 9, 2023
Received
Rivals
Compare Howard Horn with competitor CEOs and industry peers.